A subset of METTLs, such as METTL1, METTL7B, and NTMT1, which had higher frequency of gene alterations/overexpression in various cancers and/or were associated with poor disease prognosis, might function as cancer-promoters. This evidence concerns the gene TMT1B and cancer.